1. Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction
- Author
-
Omer Fatih Nas, Muhammed F Oztepe, Mehmet Fatih Inecikli, Güven Özkaya, Onur Kaygisiz, Cem Bilgin, Sedat Giray Kandemirli, Bursa Uludağ Üniversitesi/Tıp Fakültesi/Radyoloji Aanabilim Dalı., Bursa Uludağ Üniversitesi/Tıp Fakültesi/Üroloji Anabilim Dalı., Bursa Uludağ Üniversitesi/Tıp Fakültesi/Biyoistatistik Anabilim Dalı., Nas, Ömer F., Öztepe, Muhammed F., Bilgin, Cem, Özkaya, Güven, İnecikli, Mehmet F., Kaygısız, Onur, AAG-8561-2021, DLB-1623-2022, HHS-7433-2022, and GBB-7153-2022
- Subjects
Malignant ureteral obstruction ,Male ,Mesothelioma ,Ureter stone ,medicine.medical_treatment ,Percutaneous nephrostomy ,Benign ureteral obstruction ,urologic and male genital diseases ,Single Center ,030218 nuclear medicine & medical imaging ,Radiology, nuclear medicine & medical imaging ,Stent migration ,Breast cancer ,0302 clinical medicine ,Infection rate ,Stent ,Treatment outcome ,Urine culture ,Pancreas cancer ,Priority journal ,Urinary tract infection ,Prostate cancer ,Radiological and Ultrasound Technology ,Antibiotic agent ,Univariate analysis ,Bladder cancer ,Vesicoureteral reflux ,Gastroenterology ,Sarcoma ,Management ,Retrospective study ,surgical procedures, operative ,medicine.anatomical_structure ,Creatinine ,030220 oncology & carcinogenesis ,Retrograde ,Diagnostic imaging ,Female ,Stents ,Cohort analysis ,Uterine cervix cancer ,Antegrade ureteral stenting ,Human ,Ureteral Obstruction ,Adult ,medicine.medical_specialty ,Ovary cancer ,Balloon dilatation ,Bladder ,Urology ,Urinary system ,Urethra valve ,Major clinical study ,Urinalysis ,Article ,Bile duct carcinoma ,03 medical and health sciences ,Age ,Idiopathic disease ,Ureter ,Endometrium cancer ,Internal medicine ,Ultrasound ,medicine ,Ureter obstruction ,Humans ,Radiology, Nuclear Medicine and imaging ,Creatinine blood level ,Ureteral stenting ,Antibiotic prophylaxis ,Kidney pelvis ,Placement ,Nephrostomy, Percutaneous ,Retrospective Studies ,Digestive system cancer ,business.industry ,Pyonephrosis ,Percutaneous Nephrostomy ,Ureteroscopy ,Hepatology ,Retroperitoneal fibrosis ,equipment and supplies ,Interventional radiologist ,Stent failure ,Surgery ,Prostate hypertrophy ,Treatment failure ,Fluoroscopy ,Etiology ,Retrograde ureteral ,Risk factor ,Prediction ,business - Abstract
Objective To determine the potential predictors of antegrade ureteral stenting (AUS) failure in patients with malignant and benign ureteral obstruction. Method We retrospectively evaluated 116 AUS procedures performed in 80 patients for ureteral obstruction due to malignant and benign causes. Variables such as etiology for obstruction, ureter shape, previous treatment regimen, history of ileal loop diversion, and presence of percutaneous nephrostomy were recorded. Univariate and multivariate logistic regression methods were used between these variables and stent failure. Results Antegrade ureteral stenting was performed as single stage in 24 procedures (n: 24/116, 21%) and performed as a two-step approach after percutaneous nephrostomy in 92 procedures (n: 92/116, 79%). Ureteral stent was successfully deployed in 112 AUS procedures (n: 112/116, 96.5%). In 35 of these successful procedures, the patients were referred to our department due to prior failed retrograde ureteral stenting (RUS). Subsequent stent failure occurred in 40 procedures after a median interval of 39 days. Pre-stenting percutaneous nephrostomy (PN) was a statistically significant risk factor for stent failure (p: 0.041), and age showed an inverse relationship with stent failure (p: 0.008). Complications in early (within the first 30 days after procedure) and late stage occurred in a total of 17 procedures. Early complications included urinary tract infection (n: 11), stent migration (n: 3), and malposition (n: 1). Late complications (after 30 days) were urinary tract infection (n: 1) and stent migration (n: 1). Conclusion This study suggests that AUS can be performed effectively in both benign and malignant ureteral obstructions including cases with prior failed RUS. Two-step AUS after percutaneous nephrostomy was found to be a significant risk factor for subsequent stent failure in our study cohort.
- Published
- 2020
- Full Text
- View/download PDF